Novel Therapeutic Approaches in Cardiovascular Medicine
Price:
$7 600.00
Full Title: Stakeholder Opinions: Novel Therapeutic Approaches in Cardiovascular Medicine - Lack of market prospects for biologics expose an opportunity for cell and gene therapies
Introduction
At the forefront of novel technologies; momentum is steadily building for the development of stem cell products to address cardiovascular disease. The most active areas are those with high clinical unmet need heart failure, cardiomyopathy and ishemic heart disease.
Scope
Analysis of the current unmet needs in cardiovascular disease markets
Opinion leader commentary on key clinical trials and market landscape
Review of the clinical and commercial status of stem cell therapy for cardiovascular disease
Review of the clinical and commercial status of gene therapy for cardiovascular disease
Highlights
Datamonitor’s analysis demonstrates how the most innovative drugs offer the greatest growth potential for their respective markets. In the mature cardiovascular market, commercial success must be derived from innovative approaches with unique clinical benefits.The array of innovative gene and cell products emerging from young companies exposes investment opportunities for venture capitalists, Big Pharma, as well as partnering opportunities for technology companies that can offer compatible catheters, or cell delivery devices.There awaits an outstanding commercial opportunity for innovators who address clinical unmet need in this market, as a number of companies will see their key revenue generators melt away as they lose patent protection.
Reasons to Purchase
Understand the need for innovation in the cardiovascular market.
Up to date insight into the commercial and clinical status of cardiovascular gene and cell therapies
Understand the barriers to commercialization of novel therapies, with expert commentary
